Methods for treating Parkinson's disease with cholinesterase inhibitors
OwnerRaymond Prattinventor
Life of this patent
Estimating the term…
Abstract
The invention provides methods for treating Parkinson's disease by administering a therapeutically effective amount of at least one cholinesterase inhibitor compound, a pharmaceutically acceptable salt thereof, or a stereoisomer thereof. A preferred cholinesterase inhibitor compound is donepezil, a pharmaceutically acceptable salt thereof, or a stereoisomer thereof.
Claims28
A method for treating dementia in a patient with Parkinson's disease comprising orally administering about 5 milligrams to about 10 milligrams of a compound of formula IV or a pharmaceutically acceptable salt thereof, wherein the compound of formula IV is:
- 20
- or a stereoisomer thereof.
A method for treating dementia in a patient with Parkinson's disease comprising administering a therapeutically effective amount of a compound of formula IV or a pharmaceutically acceptable salt thereof,
- wherein the compound of formula IV is:
- 23
- or a stereoisomer thereof.
A method for treating Parkinson's disease in a patient in need thereof comprising administering a therapeutically effective amount of a compound of formula IV or a pharmaceutically acceptable salt thereof, wherein the compound of formula IV is:
- 26
- or a stereoisomer thereof.
Dependencies are inferred from the claim text.